These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 38303571

  • 1. Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study.
    Blankenship CR, Betthauser KD, Hencken LN, Maamari JA, Goetz J, Giacomino BD, Gibson GA.
    Ann Pharmacother; 2024 Oct; 58(10):1003-1012. PubMed ID: 38303571
    [Abstract] [Full Text] [Related]

  • 2. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE, Miano TA, Patel GP, Hammond DA.
    Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
    [Abstract] [Full Text] [Related]

  • 3. Vasopressor therapy in critically ill patients with shock.
    Russell JA.
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [Abstract] [Full Text] [Related]

  • 4. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
    Flannery AH, Owen GD, Coz A, Thompson Bastin ML, Patel K.
    Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
    [Abstract] [Full Text] [Related]

  • 5. Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction.
    Ducrocq N, Kimmoun A, Furmaniuk A, Hekalo Z, Maskali F, Poussier S, Marie PY, Levy B.
    Anesthesiology; 2012 May; 116(5):1083-91. PubMed ID: 22407285
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 7. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA, Lee T, Singer J, De Backer D, Annane D.
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [Abstract] [Full Text] [Related]

  • 8. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N.
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [Abstract] [Full Text] [Related]

  • 9. Effect of norepinephrine on the outcome of septic shock.
    Martin C, Viviand X, Leone M, Thirion X.
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [Abstract] [Full Text] [Related]

  • 10. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A.
    PLoS One; 2015 Aug; 10(8):e0129305. PubMed ID: 26237037
    [Abstract] [Full Text] [Related]

  • 11. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E, CATS Study Group.
    Lancet; 2007 Aug 25; 370(9588):676-84. PubMed ID: 17720019
    [Abstract] [Full Text] [Related]

  • 12. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, Seneff MG.
    Crit Care; 2014 Oct 06; 18(5):534. PubMed ID: 25286986
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS, Ostermann M, Forni L, Tidmarsh GF.
    Crit Care; 2019 Apr 16; 23(1):124. PubMed ID: 30992045
    [Abstract] [Full Text] [Related]

  • 15. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H.
    JAMA; 2017 Apr 11; 317(14):1433-1442. PubMed ID: 28322415
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of Vasopressin for Vasoplegic Shock in Patients With Preoperative Left Ventricular Dysfunction After Cardiac Surgery: A Propensity-Score Analysis.
    Cheng Y, Pan T, Ge M, Chen T, Ye J, Lu L, Chen C, Zong Q, Ding Y, Wang D.
    Shock; 2018 Nov 11; 50(5):519-524. PubMed ID: 29424795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.